List of bibliographic references
Number of relevant bibliographic references: 19.
Ident. | Authors (with country if any) | Title |
---|
000016 (2020) |
M. Silberstein | Vitamin D: A simpler alternative to tocilizumab for trial in COVID-19? |
000097 (2020) |
Weiyi Tan ; Jamil Aboulhosn | The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease |
000101 (2020) |
Mohammed Shah ; Derek M. Yellon ; Sean M. Davidson | The Role of Extracellular DNA and Histones in Ischaemia-Reperfusion Injury of the Myocardium |
000122 (2020) |
Timothy M. Smith ; Anuj Tharakan ; Rebecca K. Martin | Targeting ADAM10 in Cancer and Autoimmunity |
000206 (2020) |
Christos Koutsianas ; Konstantinos Thomas ; Dimitrios Vassilopoulos | Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations |
000227 (2020) |
Lauren E. Lee [États-Unis] ; Bradley W. Beeler [États-Unis] ; Brendan C. Graham [États-Unis] ; Andrew P. Cap [États-Unis] ; Nay Win [Royaume-Uni] ; Frederick Chen [Royaume-Uni] | Posttransfusion hyperhemolysis is arrested by targeting macrophage activation with novel use of Tocilizumab. |
000297 (2020) |
Jie Xiao [République populaire de Chine] ; Tian Wang [République populaire de Chine] ; Yi Xu [République populaire de Chine] ; Xiaozhen Gu [République populaire de Chine] ; Danyang Li [République populaire de Chine] ; Kang Niu [République populaire de Chine] ; Tiandong Wang [République populaire de Chine] ; Jing Zhao [République populaire de Chine] ; Ruiqing Zhou [République populaire de Chine] ; Hui-Li Wang [République populaire de Chine] | Long-term probiotic intervention mitigates memory dysfunction through a novel H3K27me3-based mechanism in lead-exposed rats |
000320 (2020) |
Rachel A. O Eefe ; Neil E. Bhola ; David S. Lee ; Daniel E. Johnson ; Jennifer R. Grandis | Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance |
000331 (2020) |
Anne Y. Liu [États-Unis] | Infectious Implications of Interleukin-1, Interleukin-6, and T Helper Type 2 Inhibition. |
000334 (2020) |
Amin Gasmi [France] ; Sadaf Noor [Pakistan] ; Torsak Tippairote [Thaïlande] ; Maryam Dadar [Iran] ; Alain Menzel [France] ; Geir Bj Rklund [Norvège] | Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic |
000369 (2020) |
| Genetic Basis of Myocarditis: Myth or Reality? |
000376 (2020) |
Theodore A. Henderson [États-Unis] ; Muriel J. Van Lierop [États-Unis, Canada] ; Mary Mclean [États-Unis, Canada] ; John Michael Uszler [États-Unis] ; John F. Thornton [États-Unis, Canada] ; Yin-Hui Siow [États-Unis, Canada] ; Dan G. Pavel [États-Unis] ; Joe Cardaci [États-Unis, Australie] ; Phil Cohen [États-Unis, Canada] | Functional Neuroimaging in Psychiatry—Aiding in Diagnosis and Guiding Treatment. What the American Psychiatric Association Does Not Know |
000393 (2020) |
Dinesh Khanna ; Donald P. Tashkin ; Christopher P. Denton ; Elisabetta A. Renzoni ; Sujal R. Desai ; John Varga | Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease |
000412 (2020) |
Sathana Ingaralingam [Royaume-Uni] ; Saaeha Rauz [Royaume-Uni] ; Philip I. Murray [Royaume-Uni] ; Robert J. Barry [Royaume-Uni] | Effectiveness of pharmacological agents for the treatment of non-infectious scleritis: a systematic review protocol |
000458 (2020) |
Kassandra Lanchais ; Frederic Capel ; Anne Tournadre [France] | Could Omega 3 Fatty Acids Preserve Muscle Health in Rheumatoid Arthritis? |
000511 (2020) |
Somy Yoon ; Gwang Hyeon Eom | Chimeric Antigen Receptor T Cell Therapy: A Novel Modality for Immune Modulation |
000559 (2020) |
Henning Ulrich [Brésil] ; Micheli M. Pillat | CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement |
000578 (2020) |
Marco Cavaco ; Diana Gaspar ; Miguel Arb Castanho ; Vera Neves | Antibodies for the Treatment of Brain Metastases, a Dream or a Reality? |
000580 (2020) |
Jonghee Hong [Corée du Sud] ; Minji Bang [Corée du Sud] | Anti-inflammatory Strategies for Schizophrenia: A Review of Evidence for Therapeutic Applications and Drug Repurposing |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "yet"
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i \
-Sk "yet" \
| HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= 2020
|étape= Analysis
|type= indexItem
|index= AbsEn.i
|clé= yet
}}
| This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 | |